The Department of Defense has selected Denmark's Bavarian Nordic to develop a vaccine against two potential biological pathogens deemed to be threats to national security.
Terumo BCT, the blood-focused division of the Japanese med tech giant, has signed a deal with the U.S. Department of Defense to share costs in the development of a device that can treat donated blood used in emergency transfusions.
Founded just 5 years ago, Combat Medical Systems nailed down an $86 million U.S. Department of Defense contract to provide a slew of medical equipment and devices for military and federal agencies over the next 5 years.
Sarepta Therapeutics is getting closer to developing a therapy to treat a rare animal-borne disease considered a bioterrorism threat by the Centers for Disease Control and Prevention.
The big defense contractor General Dynamics is hiring a team to help it execute on a $41.8 million contract to develop new drugs, devices and vaccines for the military.
A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.
Luminex has signed an $11.5 million deal with the Department of Defense, tasked with developing a hand-held diagnostics tool that can detect biothreat agents.
The Department of Defense has awarded a one-year grant to SRI International's bioscience division to develop an orally administered multiple sclerosis drug.
Tinnitus is the most common disability for American vets, and new technology could allow doctors to treat the condition.
NeoStem, a New York-based biopharmaceutical company, has been awarded almost $1.8 million from the U.S. Department of Defense to develop the company's Very Small Embryonic-Like (VSEL) stem cell